This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Altergon Sa, Ibsa Institut Biochemique S.a.. Active years: 2008-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Malnate, IT (2008 - 2012)
- Sorengo, CH (2020 - 2021)
Company Filing History:
Years Active: 2008-2021
Title: The Innovative Contributions of Marco Pizzutti
Introduction
Marco Pizzutti, an accomplished inventor based in Sorengo, Switzerland, has made significant strides in the field of biochemistry with a focus on thyroid hormone solutions. With a total of four patents to his name, he has demonstrated a commitment to innovation and scientific advancement.
Latest Patents
Among his noteworthy inventions is the "High-stability packaged solutions of T4 thyroid hormone." This invention involves highly stable, alcohol-free, water-glycerol solutions of T4 thyroid hormone, specifically designed to minimize T3 impurity levels. The innovative aspect lies in the use of multi-barrier containers, which incorporate several layers of specialized materials to prevent contact between the solution and the external environment, enhancing stability and efficacy.
Career Highlights
Marco has contributed to several prominent companies, including Altergon SA and Ibsa Institut Biochemique S.A. His work in these organizations has been instrumental in advancing the understanding and application of thyroid hormone treatments.
Collaborations
Throughout his career, Marco has collaborated with notable professionals, including Giorgio Zoppetti and Nadia Puppini. Their collective expertise has fostered a dynamic environment conducive to research and innovation in hormonal therapies.
Conclusion
Marco Pizzutti's contributions to the field of biochemistry, particularly in developing stable T4 thyroid hormone solutions, underscore his role as a key innovator in the industry. His patents reflect a dedication to improving medical treatments and enhancing the quality of life for patients reliant on hormonal therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
